News & Analysis Latest News & Analysis
Our Opinion Drug Approvals Filings R&D Deals Patents  
Free Content
Generics still doing well amongst small-caps in first half (July 03, 2009)
J&J comes riding to Elan’s rescue (July 02, 2009)
Generic players continue to impress in the first half (July 01, 2009)
BioSante appears to see something in Cell Genesys beyond its cash (June 30, 2009)
EventAnalyzer: Weekly Market Movers (to 26 Jun 09) (June 29, 2009)
Comment
CombinatoRx finds that reversing is the way forward (July 03, 2009)
J&J comes riding to Elan’s rescue (July 02, 2009)
Discovery Labs finds disappointment at end of the journey (July 02, 2009)
Acorda's licensing deal misses the M&A mark (July 01, 2009)
AMAG poised to shoot from the blocks following Feraheme approval (July 01, 2009)
Analysis
Generics still doing well amongst small-caps in first half (July 03, 2009)
Chantix warnings strengthened but lack of competition will mitigate damage (July 03, 2009)
Sanofi-Aventis scores important approval goal with Multaq (July 02, 2009)
Generic players continue to impress in the first half (July 01, 2009)
Turning point for sales and R&D spend forecast for 2009 (June 30, 2009)
EventAnalyzer
EventAnalyzer: Daily Market Movers (2 July 2009) (July 03, 2009)
EventAnalyzer: Weekly Market Movers (to 26 Jun 09) (June 29, 2009)

Display All Stories

Calendar of Events Latest Events
Overview Financial Results Conferences Approvals (PDUFA)  
Calendar of Events

EvaluatePharma®’s Calendar of Events is the first fully comprehensive online service to track events impacting shareholder value, including:

  • PDUFA data
  • Filings and approvals
  • Clinical trial initiation and results
  • Patent expiries and generic launches

Contact us to find out more

Read more about our Calendar of Events

About EvaluatePharma®

Our expertise is trusted and relied upon by the top global pharma and biotech companies, the investment community and leading consultancies - Request a Free Trial to find out why.

How to access FREE content

  • Search the content using the search box at the top of every page
  • Browse content by Company, Product, Generic Name, Therapeutic Category or Indication using "Browse By" link from the navigation bar
  • Create Peer Groups to compare Companies using "Peer Groups" link from the navigation bar

Download our brochure to discover Analysis & Insight Exclusive to EvaluatePharma

From Business Development & Licensing to Investment Banking see our range of Solutions.

Request a Free Trial to access our full service

Welcome to EvaluatePharma®

The premier source for pharma and biotech analysis delivering exclusive, trusted commercial insight into industry performance for over 10 years.

NEW: World Preview 2014 - download report

The Queen's Awards for Enterprise: International Trade 2009


WINNER OF QUEEN'S AWARD
FOR ENTERPRISE: INTERNATIONAL
TRADE 2009

Read more


You are currently a Guest User – giving you FREE access to a selection of historical analyses and insights from EvaluatePharma®.

Options:

  1. Access FREE content as a Guest User
  2. Register Now for FREE to access more content including 2007 Product Sales and Rankings
  3. Request a Free Trial for full access to EvaluatePharma or Subscribe Now

Find out why so many corporations rely on Our Products, including EvaluatePharma Alpha, to shape their view of the future performance of their industry.

Company & Product Rankings Commercial rankings - leading products and companies
MS: Top 5 Products 2010 Diabetes: Top 5 Companies 2010  
     Note:  Worldwide market share for Multiple Sclerosis products in 2010, based on company
     consolidated sales.
     Source: EvaluatePharma® consensus forecasts
Deals Licensing and M&A
Latest M&A Licensing: Top 10 2008 News  
Deal Announcement DateDeal Announcement Date Target Company or Business Unit Deal Value ($m) Acquiring Company M&A Deal Status
6/23/2009 Edwards Lifesciences' Hemofiltration Product Line 65 Baxter International Open
6/15/2009 Symphony Allegro - Alexza Pharmaceuticals Open
5/29/2009 CuraGen 95 Celldex Therapeutics Open
5/21/2009 Cougar Biotechnology 970 Johnson & Johnson Open
5/20/2009 EBEWE Pharma's Injectable Generics Business 1,200 Novartis Open
5/18/2009 Victory Pharma 150 Shionogi Open
5/18/2009 IDM Pharma 67 Takeda Open
5/12/2009 Aspen Pharmacare - GlaxoSmithKline Open
5/8/2009 EMO-FARM 28 Valeant Pharmaceuticals Closed
5/7/2009 Isotechnika 11 Paladin Labs Open